QTL for chronic alcohol withdrawal severity on Chr14 at D14mit160 (75.81 Mbp , Build 37)
Description:
chronic alcohol withdrawal severity spans 50.81 - 100.81 Mbp (NCBI Build 37) on Chr14. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Bergeson SE, Kyle Warren R, Crabbe JC, Metten P, Gene Erwin V, Belknap JK
QTL associated with dystrophic cardiac calcinosis 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (30304100)
QTL for nicotine sensitivity on Chr14 at D14Mit155 (49.05 Mbp , Build 37)
Description:
nicotine sensitivity spans 24.05 - 74.05 Mbp (NCBI Build 37) on Chr14. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for METH responses for home cage activity on Chr14 at Gnrh (75.38 Mbp , Build 37)
Description:
METH responses for home cage activity spans 50.38 - 100.38 Mbp (NCBI Build 37) on Chr14. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for METH responses for climbing on Chr14 at Es10 (78.19 Mbp , Build 37)
Description:
METH responses for climbing spans 53.19 - 103.19 Mbp (NCBI Build 37) on Chr14. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL associated with insulin dependent diabetes susceptibility 12. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (35170432)
Neocortex Gene Expression Correlates for MDMA_ACT_MDA_1 measured in BXD RI Females & Males obtained using GeneNetwork Neocortex ILM6v1.1 (Feb08) RankInv. The MDMA_ACT_MDA_1 measures Locomotor response of 10 mg/kg MDMA injected on Day 2 under the domain MDMA. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
QTL associated with B.burgdorferi-associated arthritis 21. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (60447235)
Authors:
Roper RJ, Weis JJ, McCracken BA, Green CB, Ma Y, Weber KS, Fairbairn D, Butterfield RJ, Potter MR, Zachary JF, Doerge RW, Teuscher C
QTL associated with resistance to thymic deletion 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (63002280)
Authors:
Liston A, Lesage S, Gray DH, O\'Reilly LA, Strasser A, Fahrer AM, Boyd RL, Wilson J, Baxter AG, Gallo EM, Crabtree GR, Peng K, Wilson SR, Goodnow CC
Genes with particular expression in the Entorhinal area, lateral part, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Gustatory areas, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Anteromedial visual area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the posteromedial visual area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, upper limb, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Posterior parietal association areas, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, nose, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Entorhinal area, medial part, dorsal zone, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary visual area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Posterolateral visual area, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, mouth, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, barrel field, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Taenia tecta, dorsal part, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, trunk, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
Genes with particular expression in the Primary somatosensory area, lower limb, layer 4. Data represent fold expression difference in structure versus grey matter average expression.
GeneWeaver